Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity
NCT02705716
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
409
Enrollment
INDUSTRY
Sponsor class
Conditions
Dentin Sensitivity
Interventions
OTHER:
0.454% w/w stannous fluoride (1100ppm fluoride)
OTHER:
0.76% sodium monofluorophosphate (1000ppm fluoride)
Sponsor
GlaxoSmithKline